FdaApplication

NDA 015103

Back to search

Identifiers

Properties

PropertyValue
applicant_nameSANOFI AVENTIS US LLC
application_typeNDA

Products (2)

ProductActive ingredientStrengthDosage form
DEMI-REGROTONCHLORTHALIDONE; RESERPINE25MG;0.125MGTABLET;ORAL
REGROTONCHLORTHALIDONE; RESERPINE50MG;0.25MGTABLET;ORAL

2 products